Skip to main
University-wide Navigation

UK's Sanders-Brown among 1st locations testing promising new Alzheimer's drug

Sanders-Brown Center on Aging is now a site for the first-ever clinical trial testing the effect lecanemab has in people with no cognitive symptoms of Alzheimer’s disease but have amyloid present in their brains.

Markesbery Symposium continues to honor the legacy of its namesake

UK's Sanders-Brown Center on Aging (SBCoA) will host its 12th annual Markesbery Symposium on Aging and Dementia this weekend.

Agenda set for 12th annual Markesbery Symposium scientific session; last call for abstracts

The University of Kentucky Sanders-Brown Center on Aging will hold the 12th annual Markesbery Symposium on Aging and Dementia on Nov. 18 and 19.

Sanders-Brown researcher receives $1.7 million to study adverse effects of Alzheimer’s drugs

Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.

UK researcher explores multisensory approach as potential treatment for Alzheimer’s patients

The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.

Journal announces UK's Donna Wilcock as new editor-in-chief

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

Sanders-Brown researchers receive $20.5 million from National Institute on Aging

The award exemplifies team science, helping to support 35 researchers across six different labs on four main projects on astrocytes.

Sanders-Brown director receives funding to advance work

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.

Honoring University Research Professor Peter Nelson

Peter T. Nelson, M.D., Ph.D., professor of pathology and laboratory medicine at the University of Kentucky College of Medicine and director of neuropathology at the Sanders-Brown Center on Aging, has been named one of 14 University Research Professors.

UK Develops Support for People With Mild Cognitive Impairment, Caregivers

College of Social Work's Allison Gibson, Ph.D., is working to address a lack of information and services for people with a diagnosis of mild cognitive impairment, which often leads to dementia and Alzheimer's disease.